PREPARATION AND EVALUATION OF SUSTAINED RELEASE TABLET BY USING NATURAL GUM AS RELEASE RETRADANT
P. Sapna*, Dr. P. Arun, P. Shailendra, P. Bhavesh and D. Neelesh
Abstract
Despite many advances in the development of oral hypoglycaemic
agents, an ideal drug for treating Type 2 diabetes is still a distant. The
age-old molecules such as sulfonylureas and biguanides are still
considered drugs of choice because of their well-studied mode of
action, safety, better tolerability and ideal pharmacodynamic effects.
Until we find an ideal drug for Type 2 diabetes, there is much scope
and interest for pharmaceutical companies to modify the
pharmacokinetics of older molecules in order to better suit larger
sections of patients his compilation is an attempt to describe the
advances in drug delivery of oralhypoglycaemic agents, particularly
the extended and sustained release formulations of glipizide and
metformin, both of which have great promise in treatment of Type 2 diabetes mellitus. The
drug selected for the present investigation was metformin hydrochloride, a biguanide, is an
orally active antidiabetic agent. It is more used in the treatment of non-insulin dependent
diabetes mellitus (NIDDM).
Keywords: Shimadzu FTIR 8700, UV Vis Doublebeam Spectrophotometer, Metformin Hcl, guar gum, sustained release tablet by using natural gum as release retardan, oral hypoglycaemic agents.
[Full Text Article]